Krystexxa
Pegloticase · Horizon Therapeutics USA, Inc.
PRESCRIPTION ONLY (USA)Krystexxa ingredients
| Active ingredient | Strength |
|---|---|
| Pegloticase | 8 mg/mL, 8 mg/50mL |
What Krystexxa is used for
Krystexxa is a specialist medicine (uric acid-specific enzyme). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Krystexxa
- Generic name
- Pegloticase
- Made by
- Horizon Therapeutics USA, Inc.
- Forms
- Injection, Solution
- Given
- Intravenous
- Drug class
- Uric Acid-specific Enzyme
- FDA approval
- Biologic licence (BLA) BLA125293
- On the US market since
- 2010
Official information
- Krystexxa prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Pegloticase)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Krystexxa?
Krystexxa (Pegloticase) is a specialist medicine made by Horizon Therapeutics USA, Inc., approved by the US FDA.
What are the ingredients of Krystexxa?
Krystexxa contains Pegloticase (8 mg/mL, 8 mg/50mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA